IP vs NEUP · P/E 43, $26.62B cap vs rev $15.0M
International Paper (IP) versus Neuphoria Therapeutics Inc (NEUP) — a side-by-side from cached financials, not a winner call.
International Paper (IP) is a packaging & containers company listed on US.
Neuphoria Therapeutics Inc (NEUP) is a biotechnology company listed on NASDAQ.
IP does not have a complete income-statement cache yet.
Latest reported NEUP revenue for 2025-03-31 was $15.0M. Net income was $11.3M. NEUP currently screens at market cap $23.6M.
IP currently screens at market cap $26.62B and trailing P/E 43.1. NEUP currently screens at market cap $23.6M.
Not investment advice. Open the IP and NEUP stock pages for the full models.
Not investment advice.